Private Equity Healthcare Investing

Private Equity International’s annual Healthcare report looks at the drivers behind PE investing in the healthcare sector today

Advances in AI, regional shifts, regulatory scrutiny, macro headwinds and long-term developments such as digitalisation are changing the way private equity firms are sourcing deal targets and implementing value-creation initiatives in their healthcare portfolios. This special delves into these trends and what they mean for private equity investment across different healthcare verticals and geographies.

Three key trends in healthcare

Fundraising for healthcare vehicles increased markedly in 2023 as PE firms continued to back businesses across a range of verticals.
A robot hand holding a white and orange medicinal pill between forefinger and thumb

How AI is reframing PE healthcare investing

Advances in artificial intelligence, particularly generative AI, could have a transformative impact on the healthcare industry, but PE firms must be mindful to separate hype from genuine value-creation potential.




As private equity firms continue to hunt for assets in subsectors such as life sciences, healthtech and healthcare services, this report explores how GPs are navigating rising competition and macro headwinds. Plus, we look at the drivers behind GP-led secondaries deals involving healthcare-related assets and examine how PE is addressing healthcare inequalities.

Three key trends in PE healthcare

PE interest in healthcare is in good shape despite suffering some macroeconomic side effects.

Private equity locks in on life sciences

As the sector sustains market interest through wider volatility, GPs are sharpening their investment theses and building deeper sector and operational expertise to remain competitive.

Healthcare investors wake up to inequalities

Addressing the needs of underserved groups provides an opportunity to boost returns and achieve impact.

Healthcare front of mind for secondaries buyers

Healthcare-related assets make up a significant chunk of potential dealflow in the GP-led secondaries market given the sector’s characteristics and outlook.

CHART: Fundraising for healthcare-focused private equity is in good shape

Healthcare-focused funds gathered $14.5bn last year, with a larger average fund size helping to offset a drop in the number of vehicles closed.

Inside Mubadala’s life sciences playbook

Demographic shifts and the rising cost of care in Asia have boosted interest in the market, according to the sovereign wealth fund’s head of life sciences for direct investments in America.

The private equity industry is paying greater attention to healthcare opportunities in the wake of covid-19 lockdowns, as the sector embraces digitalisation. In this special report, we examine how the increasing pace of digital transformation in healthcare is increasing competition for assets, and what investment opportunities exist in the wellbeing and mental health sphere post-pandemic.

Digitalisation in healthcare: Top trends

The pace of digitalisation in healthcare is opening the sector to both patients and investors.

Health and tech: A compelling combination

PE firms continue to vie for assets in the increasingly digitalised healthcare market, but a selective approach is critical if they are to navigate challenges such as regulation and intense competition.

Waking up to wellbeing

Apps devoted to mental health and wellness captured the imagination of investors during the pandemic, but can the sector hold its momentum?

On the minds of the Future 40: Where next for healthcare?

Rising stars share their thoughts on the biggest trends impacting private equity activity in the healthcare sector.

Finger on the pulse: Be aware of EU healthcare regulation

PE firms backing medical device businesses should become familiar with EU regulations that are increasing costs and time-to-market, writes Alison Dennis, Taylor Wessing’s co-head of life sciences and healthcare.

No subject has been as much in the public eye over the past 18 months as healthcare. With private equity interest in the sector running at an all-time high, our A-Z of Healthcare homes in on the buyout opportunities and asks where the investor challenges lie.

Six trends in healthcare

The pandemic has brought new impetus to one of private equity’s most dynamic sectors.

Covid shines a spotlight on the importance of the healthcare sector

Whether it is the partnerships needed to develop vaccines or the remarkable strides made by telemedicine, there’s a growing appreciation that the health sector represents a dynamic source of deal opportunities.

A-Z of Healthcare: A-E

In the first part of our A-Z, we examine ancillary healthcare, biotech, covid-19, digitisation and eldercare.

A-Z of Healthcare: F-K

The second part of our A-Z looks at financing, growth, healthtech, infectious diseases, joint ownership and KOLs.

A-Z of Healthcare: L-P

The third part of our A-Z looks at logistics, mental health, nursing homes, outcomes and pharmaceuticals.

A-Z of Healthcare: Q-U

The fourth part of our A-Z looks at quality of care, R&D, scalability, tie-ups and universal healthcare.

A-Z of Healthcare: V-Z

In the final part of our A-Z we look at visualisation, wellbeing, X-rays and diagnostics, youth services and Zoom healthcare.


Click here to access Private Equity International’s in-depth special reports covering a wide array of topics, plus our digital magazines.

Subscribe now to gain unlimited access to our latest insights, analysis and reports


Private Equity International’s comprehensive database is full of intelligence relating to funds being raised worldwide, with key information on target sizes and strategies used.

Find out more now >


Copyright PEI Media

Not for publication, email or dissemination